|
Off-site Links To Legislation and Other Information |
THOMAS.gov Bill Data--The Library of Congress |
Non-partisan Budget & Spending Information |
The White House |
National and International Resources We Use |
Does Your Opinion Match the Polls? |
|
Legislation News & Report (TM) TheWeekInCongress.com (TM) Managing America: Health |
|||||||||||||||
|
TheWeekInCongress.com (TM) Week Ending October 19, 2007
H.R.970 To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes.
The bill reigns in the movement of bulk dextromethorphan, a cough suppressant drug. Distribution or possession of the drug in its ‘unfinished’ capacity is prohibited by anyone who is not registered with The Secretary of health and Human Services as a producer of the drug or device. ‘Unfinished’ means that the drug has not yet been combined with something resulting in its finished dosage form.
The drug can not be distributed to any person other than a registered person but common carriers are not prohibited from distributing the drug between registered persons.
Sponsor: Rep. Fred Upton (R-MI-6th) Vote: Passed House by voice vote October 15, 2007 Cost to the taxpayers: “CBO estimates that implementing H.R. 970 would cost less than $500,000 in 2008 and about $11 million over the 2008-2012 period, assuming the appropriation of the necessary amounts.” Earmark Certification: Not applicable to this bill. ## All Rights Reserved. © 2007 TheWeekInCongress.com(TM) No reproduction, language translation or distribution without written permission from TheWeekInCongress.com.(TM)
MORE INFORMATION
## All Rights Reserved. © 2007 TheWeekInCongress.com.(TM) No reproduction, language translation or distribution without written permission from TheWeekInCongress.com.(TM)
|
|
||||||||||||||
